315 related articles for article (PubMed ID: 29524132)
1. Allele-Specific Epigenome Editing.
Bashtrykov P; Jeltsch A
Methods Mol Biol; 2018; 1767():137-146. PubMed ID: 29524132
[TBL] [Abstract][Full Text] [Related]
2. CRISPR/Cas9 Epigenome Editing Potential for Rare Imprinting Diseases: A Review.
Syding LA; Nickl P; Kasparek P; Sedlacek R
Cells; 2020 Apr; 9(4):. PubMed ID: 32316223
[TBL] [Abstract][Full Text] [Related]
3. Correction of aberrant imprinting by allele-specific epigenome editing.
Bashtrykov P; Kungulovski G; Jeltsch A
Clin Pharmacol Ther; 2016 May; 99(5):482-4. PubMed ID: 26537177
[TBL] [Abstract][Full Text] [Related]
4. Epigenome Editing in the Brain.
Bashtrykov P; Jeltsch A
Adv Exp Med Biol; 2017; 978():409-424. PubMed ID: 28523558
[TBL] [Abstract][Full Text] [Related]
5. Development of super-specific epigenome editing by targeted allele-specific DNA methylation.
Rajaram N; Kouroukli AG; Bens S; Bashtrykov P; Jeltsch A
Epigenetics Chromatin; 2023 Oct; 16(1):41. PubMed ID: 37864244
[TBL] [Abstract][Full Text] [Related]
6. Editing the Epigenome: Overview, Open Questions, and Directions of Future Development.
Rots MG; Jeltsch A
Methods Mol Biol; 2018; 1767():3-18. PubMed ID: 29524127
[TBL] [Abstract][Full Text] [Related]
7. CRISPR/Cas9-based epigenome editing: An overview of dCas9-based tools with special emphasis on off-target activity.
Tadić V; Josipović G; Zoldoš V; Vojta A
Methods; 2019 Jul; 164-165():109-119. PubMed ID: 31071448
[TBL] [Abstract][Full Text] [Related]
8. Advances of epigenetic editing.
Gjaltema RAF; Rots MG
Curr Opin Chem Biol; 2020 Aug; 57():75-81. PubMed ID: 32619853
[TBL] [Abstract][Full Text] [Related]
9. Determinants of heritable gene silencing for KRAB-dCas9 + DNMT3 and Ezh2-dCas9 + DNMT3 hit-and-run epigenome editing.
O'Geen H; Tomkova M; Combs JA; Tilley EK; Segal DJ
Nucleic Acids Res; 2022 Apr; 50(6):3239-3253. PubMed ID: 35234927
[TBL] [Abstract][Full Text] [Related]
10. Generation of Epigenetic Disease Model Mice by Targeted Demethylation of the Epigenome.
Horii T; Morita S; Hatada I
Methods Mol Biol; 2023; 2577():255-268. PubMed ID: 36173579
[TBL] [Abstract][Full Text] [Related]
11. Zinc Fingers, TALEs, and CRISPR Systems: A Comparison of Tools for Epigenome Editing.
Waryah CB; Moses C; Arooj M; Blancafort P
Methods Mol Biol; 2018; 1767():19-63. PubMed ID: 29524128
[TBL] [Abstract][Full Text] [Related]
12. In vivo epigenome editing and transcriptional modulation using CRISPR technology.
Lau CH; Suh Y
Transgenic Res; 2018 Dec; 27(6):489-509. PubMed ID: 30284145
[TBL] [Abstract][Full Text] [Related]
13. Editing the Epigenome to Tackle Brain Disorders.
Liu XS; Jaenisch R
Trends Neurosci; 2019 Dec; 42(12):861-870. PubMed ID: 31706628
[TBL] [Abstract][Full Text] [Related]
14. CRISPR/Cas mediated epigenome editing for cancer therapy.
Ansari I; Chaturvedi A; Chitkara D; Singh S
Semin Cancer Biol; 2022 Aug; 83():570-583. PubMed ID: 33421620
[TBL] [Abstract][Full Text] [Related]
15. Designing Epigenome Editors: Considerations of Biochemical and Locus Specificities.
Sen D; Keung AJ
Methods Mol Biol; 2018; 1767():65-87. PubMed ID: 29524129
[TBL] [Abstract][Full Text] [Related]
16. A modular dCas9-SunTag DNMT3A epigenome editing system overcomes pervasive off-target activity of direct fusion dCas9-DNMT3A constructs.
Pflueger C; Tan D; Swain T; Nguyen T; Pflueger J; Nefzger C; Polo JM; Ford E; Lister R
Genome Res; 2018 Aug; 28(8):1193-1206. PubMed ID: 29907613
[TBL] [Abstract][Full Text] [Related]
17. Stabilization of Foxp3 expression by CRISPR-dCas9-based epigenome editing in mouse primary T cells.
Okada M; Kanamori M; Someya K; Nakatsukasa H; Yoshimura A
Epigenetics Chromatin; 2017; 10():24. PubMed ID: 28503202
[TBL] [Abstract][Full Text] [Related]
18. Efficient Targeted DNA Methylation with dCas9-Coupled DNMT3A-DNMT3L Methyltransferase.
Bashtrykov P; Rajaram N; Jeltsch A
Methods Mol Biol; 2023; 2577():177-188. PubMed ID: 36173573
[TBL] [Abstract][Full Text] [Related]
19. Chemical and Light Inducible Epigenome Editing.
Zhao W; Wang Y; Liang FS
Int J Mol Sci; 2020 Feb; 21(3):. PubMed ID: 32028669
[TBL] [Abstract][Full Text] [Related]
20. Programmable targeted epigenetic editing using CRISPR system in Bombyx mori.
Liu Y; Ma S; Chang J; Zhang T; Chen X; Liang Y; Xia Q
Insect Biochem Mol Biol; 2019 Jul; 110():105-111. PubMed ID: 31022512
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
